MAIA Biotechnology, Inc.

MAIA

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001878313

SEC filings (opens in a new tab)

In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding MAIA Biotechnology, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of MAIA: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	6	6	0
Shares	297.1K	71.5K	−225.6K (−75.9%)
Value	$1.04M	$246.7K	−$796.7K (−76.4%)

New holders (2)

Institutions that held MAIA Biotechnology, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to MAIA in Q1 2023
Institution	Shares	Value	% of portfolio
Renaissance Technologies LLC	20,650	$71.0K	0.00%
Tower Research Capital LLC (TRC)	2,706	$9.00K	0.00%

Sold out (2)

Institutions that held MAIA Biotechnology, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of MAIA in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Lynwood Capital Management Inc.	250,000	$878.0K
Bank of America Corp	2	$7